Why Some Physicians Still Lead With Lifestyle-First Obesity Care Despite the GLP-1 Revolution
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now prescribed to…
FDA Panel Rejects Combo Drug for PTSD
An FDA advisory panel has resoundingly rejected the supplemental new drug application for the atypical antipsychotic brexpiprazole (Rexulti,…